CN Stock MarketDetailed Quotes

Harbin Gloria Pharmaceuticals (002437)

Watchlist
  • 3.20
  • +0.04+1.27%
Market Closed May 19 15:00 CST
7.14BMarket Cap17.30P/E (TTM)

Harbin Gloria Pharmaceuticals (002437) Revenue Breakdown Overview

By Product

Currency:CNY
2025/FY
Stock NameRevenueRatio
维生素类药物954.35M44.69%
Cardio-cerebrovascular drugs593.18M27.78%
Orthopedic drugs226.84M10.62%
Electrolyte drugs158.34M7.41%
Antitumor drugs75.15M3.52%
Antiinfective drugs44.58M2.09%
其他用药领域36.44M1.71%
糖尿病类药物32.13M1.50%
镇痛类药物10.06M0.47%
Other4.38M0.21%
View all

By Industry

Currency:CNY
2025/FY
Stock NameRevenueRatio
化药行业1.95B91.34%
Traditional Chinese medicine industry180.56M8.46%
Other industries4.38M0.21%

By Country/Region

Currency:CNY
2025/FY
Stock NameRevenueRatio
Domestic2.13B99.75%
Abroad5.31M0.25%

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
Middle East conflict spreads to the stock market! How should investors respond?
On May 18 Eastern Time, Trump temporarily halted the planned 'major' military strike on Iran, citing that Gulf allies requested room for neg Show More